Successful management of refractory cases of canine demodicosis with homeopathy medicine Graphitis.
Ranjan R1, Dua K2, Turkar S2, Singh H3, Singla LD3.
Canine demodicosis is a refractory skin disease caused by excessive proliferation of mite Demodex canis. The authors describe successful treatment of two refractory cases of canine demodicosis using homeopathy medicine. After oral administration of Graphitis 200 C two drops once daily for 2 months, complete cure from the disease was observed. No adverse health effects of the medication were recorded during the treatment. Thus, it may be concluded that homeopathy medicine may be used safely for long-term management of canine demodicosis.
J Parasit Dis. 2014 Dec;38(4):417-9. doi: 10.1007/s12639-013-0269-6. Epub 2013 Mar 2.
Additional effects of homeopathy on chronic periodontitis: a 1-year follow-up randomized clinical trial.
Mourão LC1, Cataldo DM2, Moutinho H2, Fischer RG3, Canabarro A4.
The aim of this study was test the hypothesis that homeopathy (H) enhances the effects of scaling and root planing (SRP) in patients with chronic periodontitis (CP). 50 patients with CP were randomly allocated to one of two treatment groups: SRP (C-G) or SRP + H (H-G). Assessments were made at baseline and after 3 and 12 months of treatments. The local and systemic responses to the treatments were evaluated by clinical and serologic parameters, respectively. Using clinical attachment gain and reductions in HDL, LDL and Total Cholesterol, Triglycerides, Glucose and Uric acid, from baseline to 1 year, as criteria for treatment success, H-G performed significantly better than C-G. The findings of this 1-year follow-up randomized clinical trial suggest that homeopathic medicines, as an adjunctive to SRP, can provide significant local and systemic improvements for CP patients.
Complement Ther Clin Pract. 2014 Aug;20(3):141-6. doi: 10.1016/j.ctcp.2014.03.003. Epub 2014 Apr 8.
Antiplasmodial potential of homeopathic drugs Chelidonium and nosode against Plasmodium berghei infection.
Bagai U, Walter NS.
Malaria remains a major global health concern in developing regions of the world. In the present study, antimalarial efficacy of combination of two homeopathic drugs Chelidonium 30 and nosode 30 has been evaluated in vivo against Plasmodium berghei (P. berghei) infection using Peters 4-day test. Biochemical assays have been performed to assess the levels of hepatic and renal function biomarkers upon drug treatment using diagnostic kits. The combination of the drugs demonstrated considerable in vivo antimalarial activity with chemosuppression of 91.45% on day 7. The combination also significantly (p < 0.0005) enhanced the mean survival time of mice which was calculated to be 22.5 ± 6.31 days, whereas it was 8.55 ± 0.83 days in infected control. The increase in levels of the liver function marker enzymes tested in serum of treated mice were significantly less (p < 0.0005) than those observed in infected control on day 10. The study establishes the effectiveness of the combination against P. berghei in vivo along with the safety of the drugs to the liver and kidney functions of the host.
J Complement Integr Medorrhinum 2014 Sep;11(3):195-201.